Suppr超能文献

人类淋巴细胞和吞噬细胞上的新抗原决定簇(Sa)

New antigenic determinant (Sa) on human lymphocytes and phagocytes.

作者信息

Pruzanski W, Armstrong M, Roelcke D

出版信息

Blut. 1981 Nov;43(5):307-13. doi: 10.1007/BF00320954.

Abstract

Presence of antigenic determinants reacting with homogeneous IgM/kappa cold agglutinin (CA) of a new specificity, tentatively called Sa, was investigated by bithermic cytotoxicity assay and by immunofluorescence. CA Sa killed on average 38% allogeneic peripheral blood lymphocytes (PBL) and up to 74% of autologous PBL. There was preferential kill of B-PBL compared to T-PBL. Some preference toward B cells was also noted using tonsillary B and T lymphocytes. Cytotoxic activity of CA Sa against chronic lymphocytic leukemia cells of B-type was almost equal to that of potent anti-I CA and much stronger than anti-i CA. Presence of additional B-cytotoxic factor in the serum was excluded by the use of red blood cell eluate composed solely of homogeneous CA. Thymocytes and helper-type T cells from a patient with T cell chronic lymphocytic leukemia were very susceptible to the cytotoxic action of Sa. CA Sa killed 39% of monocytes, but there was almost no kill of polymorphonuclear leukocytes. Lymphocytotoxicity of CA Sa was abolished by sialyllactose and was not influenced by I-active glycoproteins. Comparison of CA Sa to CA of other specificities showed marked differences, supporting the view that Sa has new, previously unrecognized specificity.

摘要

通过双温细胞毒性试验和免疫荧光法研究了与一种新特异性的同源 IgM/κ 冷凝集素(CA)反应的抗原决定簇的存在情况,该冷凝集素暂称为 Sa。CA Sa 平均杀死 38% 的同种异体外周血淋巴细胞(PBL),最高可杀死 74% 的自体 PBL。与 T-PBL 相比,B-PBL 被优先杀伤。使用扁桃体 B 淋巴细胞和 T 淋巴细胞时,也发现对 B 细胞有一定的偏好。CA Sa 对 B 型慢性淋巴细胞白血病细胞的细胞毒性活性几乎与强效抗-I CA 相同,且比抗-i CA 强得多。通过使用仅由同源 CA 组成的红细胞洗脱液,排除了血清中存在额外 B 细胞毒性因子的可能性。来自一名 T 细胞慢性淋巴细胞白血病患者的胸腺细胞和辅助型 T 细胞对 Sa 的细胞毒性作用非常敏感。CA Sa 杀死 39% 的单核细胞,但对多形核白细胞几乎没有杀伤作用。CA Sa 的淋巴细胞毒性被唾液乳糖消除,且不受 I 活性糖蛋白的影响。将 CA Sa 与其他特异性的 CA 进行比较,发现存在明显差异,这支持了 Sa 具有新的、以前未被识别的特异性这一观点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验